ArticleBMC gastroenterology2026
Factors associated with low bone mineral density at diagnosis in pediatric Crohn's disease: a large retrospective cohort study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrohn’s disease can adversely affect bone mineral density and low bone mineral density is a concern in pediatric Crohn’s disease. We evaluated factors associated with below-average bone mineral density (z-score ≤ − 1.0) at Crohn’s disease diagnosis.
methodsWe retrospectively analyzed patients < 19 years diagnosed with Crohn’s disease at a single center. All patients underwent dual-energy x-ray absorptiometry at diagnosis. Lumbar spine (L1–L4) z-scores were used and below-average bone mineral density was defined as z–score ≤ − 1.0. Growth delay was defined according to the Paris classification.
resultsA total of 575 patients were analyzed and 27.2% had below-average bone mineral density. Compared with those with z–score > − 1.0, children with z–score ≤ − 1.0 were more often female, had lower hematocrit and weight/height/body mass index z-scores, higher Pediatric Crohn’s Disease Activity Index at diagnosis, and more frequent growth delay (all P < 0.05). Lower weight z-score (OR 0.465, P < 0.001) and growth delay (OR 1.846, P 0.011) were independently associated with below-average bone mineral density.
conclusionsLower weight z-score and growth delay are independently linked to below-average bone mineral density at Crohn’s disease diagnosis. These findings highlight the importance of evaluating bone mineral density at diagnosis and closely monitoring patients with these risk factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.